# A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

> **NCT00621881** · PHASE1 · COMPLETED · sponsor: **NicOx** · enrollment: 24 (estimated)

## Conditions studied

- Liver Disease

## Interventions

- **DRUG:** naproxcinod

## Key facts

- **NCT ID:** NCT00621881
- **Lead sponsor:** NicOx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-04
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621881, "A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00621881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*